Femtobiomed Inc.
Biotechnology ResearchView the employees at
Femtobiomed Inc.-
SANGHYUN LEE (이상현) FemtoBioMed Founder & Co-CEO
-
Seongnam, Gyeonggi, South Korea
-
Rising Star
Jun Kwon Park Femtobiomed CTO-
Yongin, Gyeonggi, South Korea
-
Top 5%
Se Mi Lee Scientist II-
Bundang-dong, Gyeonggi, South Korea
-
Rising Star
Overview
Femtobiomed is a cell engineering device manufacturing company built upon CellShot®, employing the patented ‘Partitioned Flow Transfection’. Using a multiple port cartridge, the customised mRNA is separately delivered and transfected to a targeted human primary hematopoietic cell at an optimal environment for a brief harvest prior to injection. With CellShot®, the development of novel therapies will be accelerated by immensely simplifying the existing non-viral approaches, along with significantly improved efficiency and yield. Ultimately, our patented platform instrument can provide innovative cell therapeutic options to the patient in affordable ways.
-